ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft failure"

  • 2015 American Transplant Congress

    Preformed IgA Antibodies to B2-Glycoprotein Is an Indepedent Risk Factor for Graft Thrombosis and Early Graft Loss After Renal Transplantation

    J. Morales,1 M. Serrano,3 J. Martinez,2 D. Perez,2 M. Sevilla,2 A. Amdres,3 E. Gonzalez,3 E. Paz-Artal,2 A. Serrano.2

    1Research Institute, hospital 12 de Octubre, Madrid, Spain; 2Immunology, Hospital 12 de Octubre, Madrid, Spain; 3Nephrology, Hospital 12 de Octubre, Madrid, Spain.

    Vessel trombosis represent the first cause of early graft loss (EGL)alter renal transplantation (RT). Our group recently described that preformed IgA antibodies to B2-Glycoprotein (…
  • 2015 American Transplant Congress

    Clinical Relevance of C3d-Binding Donor-Specific Antibodies in Late Kidney Allograft Failure

    J. Lan, D. Gjertson, Y. Zheng, DeKAF Investigators, E. Reed, M. Cecka.

    Path, UCLA, LA, CA.

    Background: The objective of this study was to investigate the prognostic value of C3d-binding donor-specific antibodies (DSA) in determining late kidney allograft failure.Methods: 1048 patients…
  • 2015 American Transplant Congress

    DSA Monitoring in Kidney Transplant Recipients

    F. Pean,1 M. Cooper,1 J. Verbesey,1 A. Gilbert,1 B. Javaid,1 R. Mohammed,1 O. Timofeeva,2 J. Moore,1 K. Cruz,1 R. Ghasemian,1 T. Fishbein,1 M. Grafals.1

    1Medstar Georgetown Transplant Institute, Georgetown University, Washington, DC; 2Clinical Laboratory and Histocompatibility, Georgetown University, Washington, DC.

    Introduction: The development of DSA monitoring is a new technique to detect antibodies in kidney transplant recipients. Data has shown that development of DSA post…
  • 2015 American Transplant Congress

    Live Donor Kidney Transplantation: Recipient Outcomes When the Donor Developed ESRD

    A. Muzaale, A. Massie, D. Segev.

    Johns Hopkins University, Baltimore, MD.

    Recipient outcomes when the donor developed ESRD remain uncharacterized.Method: A cohort of 99 LDKT recipients between 04/1994-11/2011, whose donors subsequently developed ESRD, was compared with…
  • 2015 American Transplant Congress

    Calcineurin-Inhibitor Conversion to mTOR Inhibitor in Renal Transplant Recipients Leads to Worse Long Term Clinical Outcomes

    A. Alvarado,1 A. Shetty,1 O. Traitanon,1 J. Leventhal,1 V. Mas,2 D. Chhabra,3 J. Matthews,1 L. Gallon.1

    1Comprehensive Transplant Center, Northwestern University, Chicago, IL; 2University of Virgina, Charlottesville, Va; 3Advocate Christ Medical Center, Chicago, IL.

    We previously reported the short-term feasibility of Calcineurin-Inhibitor (CNI) elimination in kidney transplant recipients. We now report the long-term clinical impact on renal allograft function…
  • 2015 American Transplant Congress

    Successful Management of Post Transplant Focal Segmental Glomerulosclerosis With Plasma Exchange and Rituximab

    K. Koutroutsos,1 R. Charif,1 C. Roufosse,2 J. Galliford,1 D. Taube,1 M. Loucaidou.1

    1Kidney and Transplant Centre, Imperial Healthcare NHS Trust, London, United Kingdom; 2Department of Histopathology, Imperial Healthcare NHS Trust, London, United Kingdom.

    Background: Post-transplant Focal Segmental Glomerulosclerosis (FSGS) is associated with renal allograft loss. Currently, optimal treatment remains controversial. We propose a management protocol that includes treatment…
  • 2015 American Transplant Congress

    Age-Specific Graft Failure Rates in Pediatric Heart Transplant Recipients

    B. Foster,1 M. Dahhou,1 X. Zhang,1 V. Dharnidharka,2 V. Ng,3 J. Conway.4

    1Pediatrics, Research Institute of the McGill Univ. Health Centre, Montreal, QC, Canada; 2Pediatrics, Washington Univ., St. Louis, MO; 3Pediatrics, Hospital for Sick Children, Toronto, ON, Canada; 4Pediatrics, Stollery Children's Hospital, Edmonton, AB, Canada.

    Graft failure risk has been shown to peak during emerging adulthood (18-25 y) among kidney transplant recipients. The association between age and graft failure risk…
  • 2015 American Transplant Congress

    Outcomes After Right Kidney Living Donor Transplant Are Associated With Center Volume

    R. Reed, P. MacLennan, B. Shelton, D. Sonnier, M. Hanaway, J. Goodman, C. Young, M. Deierhoi, J. Locke.

    Surgery/Transplantation, University of Alabama at Birmingham, Birmingham, AL.

    Background: Right kidney living donor transplant (RKLDT) is a high-risk, low-volume procedure that is associated with increased risk for early graft failure. It is unclear…
  • 2015 American Transplant Congress

    Does Higher Cost Improve Outcome in Pediatric Liver Transplantation?

    J. Minneman, J. Grijalva, S. Rangel, H. Kim, K. Vakili.

    Surgery, Boston Children's Hospital, Boston, MA.

    Examine the relationship between transplant-related total cost and 1-year graft failure and patient mortality rate for liver transplantation at freestanding children's hospitals.Using the Pediatric Health…
  • 2015 American Transplant Congress

    Association of Pulmonary Hypertension at Kidney Transplant Evaluation and Subsequent Outcomes Following Transplantation

    Y.-L. Lai,1 H. Wasse,2 W. Kim,3 R. Patzer.1,4

    1Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA; 2Division of Nephrology/Hypertension, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; 3Emory University School of Medicine, Atlanta, GA; 4Department of Surgery, Emory University School of Medicine, Atlanta, GA.

    Background - Pulmonary hypertension (PH) is common among patients with end stage renal disease (ESRD) who depend on dialysis before transplant, and PH is associated…
  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences